The University of Barcelona has, since yesterday, a new chair: the UB AMGEN Chair in Multiple Myeloma. Thanks to the collaboration of the American biotechnology company AMGEN, the University will be able to promote a whole series of teaching, training, information and documentation activities in the field of monoclonal gammopathy in general, and multiple myeloma, in particular.
